NEW YORK, Oct. 17, 2019 /PRNewswire/ -- Moore Kuehn,
PLLC, a securities law firm located on Wall Street in downtown
New York City, is investigating
potential claims involving the directors and officers regarding
possible breaches of fiduciary duties and other violations of law
related to merger agreements, inaccurate developments and/or
financial projections.
Genomic Health,
Inc. (NASDAQ: GHDX)
Genomic Health, Inc. may merge with Exact Sciences Corp.
(NASDAQ: EXAS). Moore Kuehn is investigating Genomic Health's board
of directors' decision to sell the company now rather than allow
shareholders to continue to participate in the company's continued
success and future growth prospects.
Carbonite, Inc.
(NASDAQ: CARB)
Before July 25, 2019, the officers
and directors of Carbonite issued positive projections and
financial forecasts despite having information to the contrary.
Specifically, the officers and directors failed to disclose
that: (i) Carbonite's Server Backup VM Edition was of poor quality
and technologically flawed; (ii) Carbonite was receiving poor
reviews and complaints from customers about the Server Backup VM
Edition; and (iii) the poor quality and technological flaws of the
Server Backup VM Edition were acting as a "disruptive" factor
throughout the Carbonite salesforce and keeping that sales
organization from closing opportunistically on several larger deals
during fiscal 2019; and (iv) as a result of the foregoing,
Carbonite lacked any reasonable basis for issuing its positive
projections and financial forecasts.
On July 25, 2019, Carbonite,
conceded that it was withdrawing the Server Backup VM Edition from
the marketplace and consequently dramatically lowered its
financial projections for fiscal 2019 and 2020. On the same
day, Carbonite's Chief Executive Officer announced he was
leaving the Company.
Moore Kuehn encourages shareholders to contact Fletcher Moore, Esq. by email at
fmoore@moorekuehn.com or telephone at (212) 709-8245. There is no
cost or obligation to you.
Moore Kuehn is a New York-based
law firm with attorneys representing investors and consumers in
class action litigation involving securities law violations,
financial fraud, breaches of fiduciary duties, and other claims.
For additional information about Moore Kuehn, please go to
http://www.moorekuehn.com/practice/new-york-securities-litigation/.
Attorney advertising. Prior results do not guarantee similar
outcomes.
Contacts:
Moore Kuehn, PLLC
Fletcher Moore, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
fmoore@moorekuehn.com
(212) 709-8245
View original content to download
multimedia:http://www.prnewswire.com/news-releases/moore-kuehn-pllc-encourages-genomic-health-inc-and-carbonite-inc-investors-to-contact-firm-300940634.html
SOURCE Moore Kuehn, PLLC
